Sunitinib for the treatment of benign and malignant neoplasms from von Hippel-Lindau disease: A single-arm, prospective phase II clinical study from the PREDIR group

por Oudard, Stéphane, Elaidi, Reza, Brizard, Mara, Rest, Céline Le, Caillet, Valérie, Deveaux, Sophie, Benoit, Gérard, Corréas, Jean-Michel, Benoudiba, Farida, David, Philippe, Gaudric, Alain, Hammel, Pascal, Joly, Dominique, Timsit, Marc Olivier, Méjean, Arnaud, Richard, Stéphane
Publicado 2016